Bioharvest Sciences (BHST) Liabilities and Shareholders Equity (2023 - 2025)

Bioharvest Sciences' Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $47.7 million for Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity rose 90.65% year-over-year to $47.7 million in Q4 2025; TTM through Dec 2025 was $137.2 million, a 33.45% increase from a year earlier, with the FY2025 full-year figure at $47.7 million, up 90.65% from the prior year.
• Liabilities and Shareholders Equity climbed to $47.7 million in Q4 2025 per BHST's latest filing, from $35.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $47.7 million in Q4 2025 and bottomed at $15.0 million in Q4 2023.
• The 3-year median for Liabilities and Shareholders Equity is $26.6 million (2025), against an average of $28.3 million.
• Biggest YoY gain for Liabilities and Shareholders Equity was 90.65% in 2025; the steepest drop was 2.9% in 2025.
• Year by year, Liabilities and Shareholders Equity stood at $15.0 million in 2023, then surged by 66.65% to $25.0 million in 2024, then soared by 90.65% to $47.7 million in 2025.
• Per Business Quant, the three latest BHST Liabilities and Shareholders Equity figures stand at $47.7 million (Q4 2025), $35.2 million (Q3 2025), and $27.8 million (Q2 2025).